openPR Logo
Press release

Genefitletics enters into a strategic partnership with Genique Lifesciences

04-06-2021 04:38 PM CET | Health & Medicine

Press release from: Genefitletics

7OCZES

7OCZES

Genefitletics has entered into a strategic partnership with Genique Lifesciences to provide Genomics & bioinformatics based preventive healthcare solutions - Curegenic. Genefitletics is a biotech company working on the intersection of genomics, gut microbiome & circadian rhythm to offer Artificial Intelligence driven hyper personalised preventive health recommendations that help users to prevent & reverse the impact of chronic diseases and improve their lives.

Genefitletics’s comprehensive biointelligence solution-Curegenic, decodes health insights and biomarkers of more than 30 chronic diseases using genetic & gut microbiome testing analysis & analyzes the interaction between food & gut microbes to provide customers with data driven personalized health recommendations. The partnership with Genique will help Genefitletics to expand its horizon in international markets & launch new biomarkers that would be able to predict chronic diseases such as diabetes, cardiovascular disease, depression, Alzhimer’s, Parkinson’s, Acid Reflux & Autism.

Genique Lifesciences, is a genomics driven healthcare company based out of Gurgaon. Genique provides solutions in the space of carrier screening, newborn screening, health, wellness, ancestry and nutrition for patients in India. The company supports Indian clients with a variety of NGS library prep kits, analysis, storage and bioinformatics tools. Genique is committed to improving healthcare outcomes by making DNA based insights easily understandable for clinicians and patients.

The company is channel partners with SOPHiA Genetics, a health tech company democratizing Data-Driven Medicine based in Switzerland; Petagene, a bioinformatics software company for data compression and storage based in Cambrige, UK; Pillar Biosciences, a leading next-generation sequencing clinical company based in Massachusetts and Sentieon that develops highly-optimized algorithms for bioinformatics applications based in San Francisco.

Mr. Sushant Kumar, CEO of Genefitletics quotes, “The current disease led model of medicine is far away from helping people prevent & reverse chronic diseases. The focus on antibiotics & surgeries to manage & suppress symptoms have dragged people towards attracting dreaded diseases such as heart stroke, gastrointestinal diseases, obesity & neurodegenerative disorders. Not to mention the price tag & long term collateral damage this outdated model has produced. We are only 1% human & our body has more foreign cells than human cells. What we require is understanding of invisible forces at work inside our body to bring a human biology science led revolution in healthcare. This will uncover a much needed solution to the biggest global epidemic- chronic inflammation. This strategic foray with Genique will enable us to usher a new science that will bring much needed human & gut microbial DNA based preventive healthcare solutions to empower people to overcome & reverse chronic diseases.”

Mr. Abhishek Das, CEO & Co-Founder quotes, “Genomics and individual DNA play a key role in determining dietary and other healthy habits required to optimise the health of people. These tests are game changers for anyone who wants to improve their health outcomes. If you know thyself, then you can shape thyself. Genique is delighted to partner with Genefitlectics to empower more people to take charge of their health with these tests.”

171, Ist Floor
AGCR Enclave, Karkardooma

Genefitletics is a biotech company working on the intersection of genomics, gut microbiome & circadian rhythm to offer Artificial Intelligence driven hyper personalised preventive health recommendations that help users to prevent & reverse the impact of chronic diseases and improve their lives.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genefitletics enters into a strategic partnership with Genique Lifesciences here

News-ID: 2266574 • Views:

More Releases for Genique

Global All-in-One 4K Endoscopic Camera System Market Size, Share, and Growth Ana …
The global market for All-in-One 4K Endoscopic Camera System was estimated to be worth US$ 2661 million in 2024 and is forecast to a readjusted size of US$ 4619 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031. QY Research (Market Research Report Publisher) announces the release of its lastest report "All-in-One 4K Endoscopic Camera System - Global Market Share and Ranking, Overall Sales and Demand
Next Generation Cancer Diagnostics Market Would Grow upto USD 31.75 Billion by 2 …
Next Generation Cancer Diagnostics Market research report encompasses the study about the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, possible future trends, and market demand and supply scenarios. The use of established statistical tools and coherent models for analysis and forecasting of market data makes this report outshining. The study encompasses a market attractiveness analysis, wherein each segment is benchmarked based
At 4.01% CAGR, Global Synthetic Leather Market Size to Hit USD 80.55 Billion by …
According to Facts and Factors, the global synthetic leather market was valued at USD 63.17 billion in 2021 and is predicted to increase at a CAGR of 4.01% to USD 80.55 billion by 2028. The study examines the market in terms of revenue in each of the leading regions, which are classified into countries. The Global Synthetic Leather Market is being driven by the increasing prevalence of osteoporosis as well as
At 4.2% CAGR, Global EMI Shielding Market Size to Surpass USD 7845.6 Million by …
According to Facts & Factors, The EMI Shielding Market was worth around USD 6129.5 million in 2021 and is estimated to grow to about USD 7845.6 million by 2028, with a compound annual growth rate (CAGR) of approximately 4.2% over the forecast period. The report analyzes the EMI Shielding Market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging
Acute Spinal Cord Injury Market is expected to reach USD 6575.65 million by 2028
Some of the objectives of the credible Acute Spinal Cord Injury report can be highlighted as analyzing the global and key region's market potential and advantage, opportunity, and challenge, restraints, and risks. Identifying significant trends, drivers, influencing factors in global and local regions. The current market scenario and future prospects of the sector have also been examined here. Moreover, this report analyzes the competitive developments such as expansions, agreements, new
Statistical Report: Global Sesame Market Size & Share to Surpass USD 8028 Millio …
The global sesame market in 2019 was approximately USD 6800 Million. The market is expected to grow above a CAGR of 2.4% and is anticipated to reach over USD 8028 Million by 2026. The outbreak of COVID-19 has resulted in a decrease in public mobility and has had a significant impact on therapeutic and surgical procedures. For example, non-immediate surgical procedures are being postponed in order to reduce the burden that